Ligand validation:6QYQ

FFO: N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid

FFO is a Ligand Of Interest in 6QYQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QYQ_FFO_D_402	55%	40%	0.136	0.903	1	1.38	3	4	0	0	100%	1
6QYQ_FFO_B_402	53%	40%	0.147	0.907	0.98	1.39	3	5	0	0	100%	1
6R2E_FFO_E_403	76%	36%	0.124	0.96	1	1.6	2	5	5	0	100%	1
7TH4_FFO_B_303	95%	47%	0.076	0.98	0.96	1.1	2	2	0	0	100%	1
8DSK_FFO_C_502	85%	10%	0.088	0.953	2.79	1.71	12	6	0	0	100%	0.468
3UWL_FFO_B_316	79%	31%	0.103	0.95	1.18	1.68	3	5	2	0	100%	1
8FSD_FFO_A_508	72%	4%	0.108	0.932	4.15	1.65	13	6	0	0	100%	0.483
1PJ7_FFO_A_2887	68%	24%	0.103	0.915	1.46	1.79	3	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.